Chronic cough is a distressing symptom experienced by approximately 37% of patients with advanced cancer. Palliation of chronic nonproductive cough should always first address the underlying cause but in some patients chronic, nonproductive cough persists and antitussive agents are required. Opioids are the gold standard cough suppressants, of which codeine is the most widely used; patients with an opioid-resistant cough often prove to be a therapeutic challenge. We report three patients with an opioid-resistant cough who achieved symptomatic relief with the peripherally acting nonopioid drug benzonatate.
Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol1995; 22: 67–72.
2.
Donnelly S, Walsh D. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care1995; 11: 27–32.
Fuller RW, Jackson DM. Physiology and treatment of cough. Thorax1990; 45: 425–430.
5.
Eddy NB, Friebel H, Hahn KJ, Halbach H. Codeine and its alternatives for pain and cough relief. The antitussive action of codeine–mechanism, methodology and evaluation. Bull WHO1969; 40: 425–454.
6.
American Society of Health-System Pharmacists Inc.AHFS drug information, 1997: 2082, 2089–2091.
7.
Martindale The Extra Pharmacopoeia, 27th edition. London: The Pharmaceutical Press, 1978.
8.
Gregoire F, Thibaudeau Y, Comeau M. The treatment of cough by a non-narcotic antitussive. Can Med Assoc J1958; 79: 180–184.
